Logo image of NEXT.OL

NEXT BIOMETRICS GROUP AS (NEXT.OL) Stock Fundamental Analysis

OSL:NEXT - Euronext Oslo - NO0010629108 - Common Stock - Currency: NOK

4.7  -0.05 (-1.05%)

Fundamental Rating

2

Taking everything into account, NEXT scores 2 out of 10 in our fundamental rating. NEXT was compared to 48 industry peers in the Electronic Equipment, Instruments & Components industry. The financial health of NEXT is average, but there are quite some concerns on its profitability. NEXT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NEXT had negative earnings in the past year.
In the past year NEXT has reported a negative cash flow from operations.
NEXT had negative earnings in each of the past 5 years.
NEXT had a negative operating cash flow in each of the past 5 years.
NEXT.OL Yearly Net Income VS EBIT VS OCF VS FCFNEXT.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M

1.2 Ratios

NEXT has a Return On Assets of -24.68%. This is amonst the worse of the industry: NEXT underperforms 83.33% of its industry peers.
NEXT has a worse Return On Equity (-31.26%) than 75.00% of its industry peers.
Industry RankSector Rank
ROA -24.68%
ROE -31.26%
ROIC N/A
ROA(3y)-39.33%
ROA(5y)-46.51%
ROE(3y)-49.73%
ROE(5y)-59.73%
ROIC(3y)N/A
ROIC(5y)N/A
NEXT.OL Yearly ROA, ROE, ROICNEXT.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100

1.3 Margins

With a decent Gross Margin value of 54.95%, NEXT is doing good in the industry, outperforming 72.92% of the companies in the same industry.
NEXT's Gross Margin has improved in the last couple of years.
NEXT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y45.94%
GM growth 5Y17.67%
NEXT.OL Yearly Profit, Operating, Gross MarginsNEXT.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

More info and screens

6

2. Health

2.1 Basic Checks

NEXT does not have a ROIC to compare to the WACC, probably because it is not profitable.
NEXT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for NEXT has been increased compared to 5 years ago.
NEXT has a worse debt/assets ratio than last year.
NEXT.OL Yearly Shares OutstandingNEXT.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
NEXT.OL Yearly Total Debt VS Total AssetsNEXT.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

NEXT has an Altman-Z score of 9.71. This indicates that NEXT is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 9.71, NEXT belongs to the best of the industry, outperforming 95.83% of the companies in the same industry.
A Debt/Equity ratio of 0.02 indicates that NEXT is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.02, NEXT belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 9.71
ROIC/WACCN/A
WACC8.63%
NEXT.OL Yearly LT Debt VS Equity VS FCFNEXT.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

2.3 Liquidity

NEXT has a Current Ratio of 4.84. This indicates that NEXT is financially healthy and has no problem in meeting its short term obligations.
NEXT's Current ratio of 4.84 is amongst the best of the industry. NEXT outperforms 95.83% of its industry peers.
NEXT has a Quick Ratio of 4.27. This indicates that NEXT is financially healthy and has no problem in meeting its short term obligations.
NEXT's Quick ratio of 4.27 is amongst the best of the industry. NEXT outperforms 95.83% of its industry peers.
Industry RankSector Rank
Current Ratio 4.84
Quick Ratio 4.27
NEXT.OL Yearly Current Assets VS Current LiabilitesNEXT.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

1

3. Growth

3.1 Past

NEXT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.02%, which is quite impressive.
Looking at the last year, NEXT shows a very strong growth in Revenue. The Revenue has grown by 109.29%.
Measured over the past years, NEXT shows a decrease in Revenue. The Revenue has been decreasing by -3.15% on average per year.
EPS 1Y (TTM)48.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.25%
Revenue 1Y (TTM)109.29%
Revenue growth 3Y12.34%
Revenue growth 5Y-3.15%
Sales Q2Q%-7.21%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NEXT.OL Yearly Revenue VS EstimatesNEXT.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
NEXT.OL Yearly EPS VS EstimatesNEXT.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 -2 -4 -6 -8 -10

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NEXT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NEXT.OL Price Earnings VS Forward Price EarningsNEXT.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NEXT.OL Per share dataNEXT.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NEXT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEXT BIOMETRICS GROUP AS

OSL:NEXT (4/25/2025, 7:00:00 PM)

4.7

-0.05 (-1.05%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-19 2025-02-19
Earnings (Next)05-14 2025-05-14
Inst Owners6.05%
Inst Owner ChangeN/A
Ins Owners6.59%
Ins Owner ChangeN/A
Market Cap541.21M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.52
P/FCF N/A
P/OCF N/A
P/B 4.33
P/tB 4.36
EV/EBITDA N/A
EPS(TTM)-0.36
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)-0.54
OCFYN/A
SpS0.62
BVpS1.08
TBVpS1.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.68%
ROE -31.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.95%
FCFM N/A
ROA(3y)-39.33%
ROA(5y)-46.51%
ROE(3y)-49.73%
ROE(5y)-59.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y45.94%
GM growth 5Y17.67%
F-Score4
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 10.6%
Cap/Sales 0.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.84
Quick Ratio 4.27
Altman-Z 9.71
F-Score4
WACC8.63%
ROIC/WACCN/A
Cap/Depr(3y)3.92%
Cap/Depr(5y)3.04%
Cap/Sales(3y)0.33%
Cap/Sales(5y)0.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.25%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)109.29%
Revenue growth 3Y12.34%
Revenue growth 5Y-3.15%
Sales Q2Q%-7.21%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-10.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.61%
OCF growth 3YN/A
OCF growth 5YN/A